Home/Filings/8-K/0001213900-26-005532
8-K//Current report

INSPIRE VETERINARY PARTNERS, INC. 8-K

Accession 0001213900-26-005532

$IVPCIK 0001939365operating

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 1:16 PM ET

Size

218.4 KB

Accession

0001213900-26-005532

Research Summary

AI-generated summary of this filing

Updated

Inspire Veterinary Reports Debt-for-Equity Exchange With Target Capital

What Happened

  • Inspire Veterinary Partners, Inc. announced on January 14, 2026 that it entered into a Cancellation and Exchange Agreement with Target Capital 1 LLC to cancel $25,000 of outstanding principal under a promissory note dated June 10, 2025 (as amended).
  • In exchange for the canceled $25,000 debt, the company issued 2,500,000 shares of its Class A common stock (par value $0.0001), using an exchange rate of $0.01 per share. The company relied on the Section 3(a)(9) exemption of the Securities Act for the transaction.

Key Details

  • Counterparty: Target Capital 1 LLC.
  • Date of agreement: January 14, 2026; original promissory note dated June 10, 2025.
  • Debt cancelled: $25,000 of principal.
  • Shares issued: 2,500,000 Class A common shares; exchange price used = $0.01/share.
  • Filing notes the exchange was an unregistered sale relying on Section 3(a)(9); the full agreement is filed as Exhibit 10.1.

Why It Matters

  • The transaction reduced the company’s liabilities by $25,000 and increased outstanding equity by 2,500,000 shares. For investors, this changes the company’s capital structure — lower debt but more shares outstanding — which can affect per-share metrics and ownership percentages.
  • Because the issuance was completed under a securities exemption (unregistered), investors should review subsequent filings for updated share counts and any further disclosures about dilution or related impacts.